Skip Navigation LinksHome > February 2012 - Volume 54 - Issue 2 > MicroRNA Profiling Identifies miR-29 as a Regulator of Disea...
Journal of Pediatric Gastroenterology & Nutrition:
doi: 10.1097/MPG.0b013e318244148b
Rapid Communication

MicroRNA Profiling Identifies miR-29 as a Regulator of Disease-associated Pathways in Experimental Biliary Atresia

Hand, Nicholas J.; Horner, Amber M.; Master, Zankhana R.; Boateng, LaTasha A.; LeGuen, Claire; Uvaydova, Marina; Friedman, Joshua R.

Supplemental Author Material
Collapse Box

Abstract

ABSTRACT: Biliary atresia (BA) is a pediatric liver disease of unknown underlying etiology, in which fibroinflammatory destruction of the extrahepatic biliary system leads to obstructive cholestasis. MicroRNAs are a class of short (18–23 nucleotide), noncoding RNA molecules, which act as negative regulators of target mRNA stability and translation. The importance of these molecules in normal and diseased liver has been demonstrated, but their potential role in the pathogenesis of BA has not been addressed. We have profiled changes in liver microRNA levels in an established mouse model of the disease, identified significantly altered transcripts, and defined the spatial expression patterns of selected microRNAs. Two of these, miR-29a/29b1, are upregulated in experimental BA. Using antisense oligonucleotide-mediated inhibition in mice, we have delineated the full set of hepatic genes regulated by miR-29 and identified 2 mRNA targets of potential pathological relevance in experimental BA, Igf1 and Il1RAP. We have used reporter assays to confirm that Igf1 and Il1RAP are direct targets of miR-29.

Copyright 2012 by ESPGHAN and NASPGHAN

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us

 

 

Twitter

twitter.com/JPGNonline